New Diagnoses of Juvenile Idiopathic Arthritis Early in the COVID-19 Pandemic
Compared with the prepandemic period, JIA was diagnosed 30% less often during the early pandemic among commercially insured children in the United States. More research is needed to understand the underlying reasons for these changes in JIA diagnosis and more recent trends.
Authors
- Carlos D. Rosé
- Kevin Haynes (ORCID: https://orcid.org/0000-0002-7087-9159)
- Daniel B. Horton (ORCID: https://orcid.org/0000-0002-1831-1339)
- Sanika Rege (ORCID: https://orcid.org/0000-0002-2405-0147)
- Amy L. Davidow (ORCID: https://orcid.org/0000-0002-3660-7627)
- Tobias Gerhard (ORCID: https://orcid.org/0000-0002-8598-5771)
- Lauren E. Parlett (ORCID: https://orcid.org/0000-0003-1240-4566)
- Akira Iizuka (ORCID: https://orcid.org/0000-0002-2545-5138)
- Stephen Crystal (ORCID: https://orcid.org/0000-0003-0366-7583)
- Amanda Neikirk (ORCID: https://orcid.org/0009-0007-5306-3135)
- Brian L. Strom (ORCID: https://orcid.org/0000-0001-5750-4232)
- Yiling Yang
- Cecilia Huang
Institutions
- Rutgers, The State University of New Jersey (US)
- Thomas Jefferson University (US)
- Wilmington University (US)
- Janssen (United States) (US)
- Institute of Aging (CA)
- New York University (US)
Publication Details
- Journal
- JCR Journal of Clinical Rheumatology
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1097/rhu.0000000000002154
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Health and Human Services
- Sanofi
- Childhood Arthritis and Rheumatology Research Alliance
- Consumer Healthcare Products Association
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- National Institute of Child Health and Human Development
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development